Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model

[1]  F. Jessen,et al.  Anticholinergic drug use and risk for dementia: target for dementia prevention , 2010, European Archives of Psychiatry and Clinical Neuroscience.

[2]  M. Boustani,et al.  Use of anticholinergics and the risk of cognitive impairment in an African American population , 2010, Neurology.

[3]  J. Campbell,et al.  Postnatal hepatic fatty acid oxidative capacity of preterm pigs receiving TPN does not differ from that of term pigs and is not affected by supplemental arachidonic and docosahexaenoic acids. , 2010, The Journal of nutrition.

[4]  J. Roh,et al.  Cholinergic anti-inflammatory pathway in intracerebral hemorrhage , 2010, Brain Research.

[5]  C. Hong,et al.  Peripheral Cytokines and Chemokines in Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.

[6]  V. Perry,et al.  Systemic inflammation and disease progression in Alzheimer disease , 2009, Neurology.

[7]  F. Pasquier,et al.  Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. , 2009, Archives of internal medicine.

[8]  V. Pavlov,et al.  Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway , 2009, Brain, Behavior, and Immunity.

[9]  E. Tobinick.  INFLAMMATORY MARKERS AND THE RISK OF ALZHEIMER DISEASE: THE FRAMINGHAM STUDY , 2008, Neurology.

[10]  Stavros J. Baloyannis,et al.  Systemic immune aberrations in Alzheimer's disease patients , 2008, Journal of Neuroimmunology.

[11]  R. Agrawal,et al.  Effect of anti-dementia drugs on LPS induced neuroinflammation in mice. , 2007, Life sciences.

[12]  Michael T. Heneka,et al.  Inflammatory processes in Alzheimer's disease , 2007, Journal of Neuroimmunology.

[13]  T. Yamazaki,et al.  Pharmacological Effects of Imidafenacin (KRP-197/ONO-8025), a New Bladder Selective Anti-cholinergic Agent, in Rats , 2007, Arzneimittelforschung.

[14]  M. Sasamata,et al.  Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance response test. , 2007, European journal of pharmacology.

[15]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[16]  J. Touchon,et al.  Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study , 2006, BMJ : British Medical Journal.

[17]  H. Soreq,et al.  Acetylcholinesterase inhibitors reduce brain and blood interleukin‐1β production , 2005, Annals of neurology.

[18]  E. Perry,et al.  Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs , 2003, Annals of neurology.

[19]  B. Pollock,et al.  Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. , 2003, Archives of general psychiatry.

[20]  Kevin J. Tracey,et al.  Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.

[21]  N. Matsuura,et al.  Effects of antimuscarinic drugs on both urinary frequency and cognitive impairment in conscious, nonrestrained rats. , 2001, Japanese journal of pharmacology.

[22]  T. Hattori,et al.  Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain , 2000, Acta Neuropathologica.

[23]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[24]  S. O’Keeffe,et al.  Drug-Induced Cognitive Impairment in the Elderly , 1999, Drugs & aging.

[25]  D L Price,et al.  A vector for expressing foreign genes in the brains and hearts of transgenic mice. , 1996, Genetic analysis : biomolecular engineering.

[26]  L. Tune,et al.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. , 1992, The American journal of psychiatry.

[27]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[28]  K. Arai,et al.  Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model. , 2010, Journal of Alzheimer's disease : JAD.

[29]  T. Harris,et al.  The metabolic syndrome, inflammation, and risk of cognitive decline. , 2004, JAMA.